Febuxostat D9

• CAT Number: I000985
• CAS Number: 1246819-50-0
• Molecular Formula: C16H7D9N2O3S
• Molecular Weight: 325.43
• Purity: ≥95%
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: 2-[3-cyano-4-[1,1,2,3,3,3-hexadeuterio-2-(trideuteriomethyl)propoxy]phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
• InChI: InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)/i1D3,2D3,8D2,9D
• InChIKey: BQSJTQLCZDPROO-KIROAFHOSA-N
• SMILES: [2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])OC1=C(C=C(C=C1)C2=NC(=C(S2)C(=O)O)C)C#N

Febuxostat D9 is a deuterated form of febuxostat, a drug used to manage hyperuricemia associated with gout by inhibiting xanthine oxidase. The nine deuterium atoms replace hydrogen atoms in the molecule, providing a stable isotopic label for enhanced precision in pharmacokinetic and metabolic studies. This labeled compound is valuable for tracking the drug’s absorption, distribution, metabolism, and excretion, allowing researchers to study drug interactions and optimize therapeutic strategies. Its applications extend to pharmaceutical research and drug development, where it helps improve understanding of febuxostat’s behavior and efficacy in treating gout and related conditions.